DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
+$72.1M |
| 2 |
Indivior
INDV
|
+$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
+$45.7M |
| 4 |
Merus
MRUS
|
+$32.9M |
| 5 |
Viatris
VTRS
|
+$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$102M |
| 2 |
Surgery Partners
SGRY
|
+$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$57.6M |
| 4 |
BioNTech
BNTX
|
+$49.8M |
| 5 |
Integra LifeSciences
IART
|
+$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Rocket Companies
RKT
$42.2B
| $237K | ﹤0.01% |
+12,347
| New | +$237K |
|
402
CMS Energy
CMS
$21.2B
| $233K | ﹤0.01% |
3,297
-11,057
| -77% | -$781K |
|
403
Amicus Therapeutics
FOLD
$2.42B
| $232K | ﹤0.01% |
21,723
-8,029
| -27% | -$85.8K |
|
404
KLA
KLAC
$120B
| $232K | ﹤0.01% |
+299
| New | +$232K |
|
405
Jacobs Solutions
J
$17.2B
| $230K | ﹤0.01% |
+1,778
| New | +$230K |
|
406
Cross Country Healthcare
CCRN
$460M
| $230K | ﹤0.01% |
+17,125
| New | +$230K |
|
407
Dow Inc
DOW
$16.9B
| $226K | ﹤0.01% |
+4,140
| New | +$226K |
|
408
Unitil
UTL
$799M
| $225K | ﹤0.01% |
+3,712
| New | +$225K |
|
409
Skyworks Solutions
SWKS
$11.2B
| $224K | ﹤0.01% |
+2,268
| New | +$224K |
|
410
Onto Innovation
ONTO
$5.05B
| $223K | ﹤0.01% |
1,073
-1,362
| -56% | -$283K |
|
411
Globe Life
GL
$11.3B
| $218K | ﹤0.01% |
2,057
-3,013
| -59% | -$319K |
|
412
Adeia
ADEA
$1.66B
| $217K | ﹤0.01% |
+18,254
| New | +$217K |
|
413
Axcelis
ACLS
$2.58B
| $217K | ﹤0.01% |
2,067
-2,154
| -51% | -$226K |
|
414
Repligen
RGEN
$6.63B
| $211K | ﹤0.01% |
1,418
-1,944
| -58% | -$289K |
|
|
STR
415
DELISTED
Sitio Royalties
STR
| $210K | ﹤0.01% |
+10,072
| New | +$210K |
|
416
Ardelyx
ARDX
$1.56B
| $209K | ﹤0.01% |
+30,354
| New | +$209K |
|
417
Flywire
FLYW
$1.62B
| $197K | ﹤0.01% |
+12,001
| New | +$197K |
|
418
WisdomTree
WT
$2B
| $194K | ﹤0.01% |
+19,462
| New | +$194K |
|
419
KeyCorp
KEY
$21.1B
| $172K | ﹤0.01% |
+10,252
| New | +$172K |
|
420
Applied Optoelectronics
AAOI
$1.42B
| $171K | ﹤0.01% |
+11,981
| New | +$171K |
|
421
UiPath
PATH
$6.35B
| $171K | ﹤0.01% |
+13,391
| New | +$171K |
|
422
3D Systems Corporation
DDD
$272M
| $160K | ﹤0.01% |
56,349
+31,222
| +124% | +$88.7K |
|
423
Gannett
GCI
$606M
| $154K | ﹤0.01% |
+27,331
| New | +$154K |
|
424
KalVista Pharmaceuticals
KALV
$784M
| $153K | ﹤0.01% |
13,255
+2,414
| +22% | +$28K |
|
425
Chegg
CHGG
$171M
| $151K | ﹤0.01% |
+85,244
| New | +$151K |
|